<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">nss</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35299629</article-id>
      <article-id pub-id-type="pmc">8922359</article-id>
      <article-id pub-id-type="publisher-id">348580</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S348580</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The Relationship Between HIF1α and Clock Gene Expression in Patients with Obstructive Sleep Apnea</article-title>
        <alt-title alt-title-type="running-authors">Xie et al</alt-title>
        <alt-title alt-title-type="running-title">Xie et al</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7471-0943</contrib-id>
          <name>
            <surname>Xie</surname>
            <given-names>Ting</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="ft0001" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Guo</surname>
            <given-names>Dan</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="ft0001" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Luo</surname>
            <given-names>Jinmei</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="an0001" ref-type="corresp"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guo</surname>
            <given-names>Zijian</given-names>
          </name>
          <xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Sumei</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Anqi</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Xiaoxi</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Xiaona</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cao</surname>
            <given-names>Wenhao</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Su</surname>
            <given-names>Linfan</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guo</surname>
            <given-names>Junwei</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>Rong</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xiao</surname>
            <given-names>Yi</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
        </contrib>
        <aff id="aff0001"><label>1</label><institution>Department of Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College</institution>, <addr-line>Beijing</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0002"><label>2</label><institution>Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College</institution>, <addr-line>Beijing</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0003"><label>3</label><institution>Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College</institution>, <addr-line>Beijing</addr-line>, <country>People’s Republic of China</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="an0001">Correspondence: Jinmei Luo, <institution>Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College</institution>, <addr-line>Beijing</addr-line>, <country>People’s Republic of China</country>, <phone>Tel +86 010 69155037</phone>, Email palmljm@126.com</corresp>
        <fn id="ft0001">
          <label>*</label>
          <p><citation_analysis attribute="neither">These authors contributed equally to this work</citation_analysis></p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>08</day>
        <month>3</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2022</year>
      </pub-date>
      <volume>14</volume>
      <fpage>381</fpage>
      <lpage>392</lpage>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>11</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>2</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2022 Xie et al.</copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>Xie et al.</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref>
          <license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <sec id="s2001">
          <title>Purpose</title>
          <p><citation_analysis attribute="neither">In this study, we aimed to investigate the precise relationship between hypoxia-inducible factor 1α (HIF1α), circadian clock genes, and OSA.</citation_analysis></p>
        </sec>
        <sec id="s2002">
          <title>Methods</title>
          <p><citation_analysis attribute="neither">We recruited 21 patients with OSA and 22 age-matched controls who underwent polysomnography and had their peripheral blood collected on the evening before and the morning after sleep. OSA was defined as an apnea hypopnea index (AHI) ≥15 events/h. Patients in which T90 &gt; 0 were defined as having nocturnal hypoxemia (NH) and were referred to as the NH group. The mRNA levels of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α, HIF1β</italic></citation_analysis><citation_analysis attribute="neither"> and several clock genes (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Timeles</italic></citation_analysis><citation_analysis attribute="neither">s, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Clock, Bmal1, Per1, Per2, Per3, Cry1, Cry2, Ck1δ, Rorα, NR1D1</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">NPAS2)</italic></citation_analysis><citation_analysis attribute="neither"> were determined by RT-qPCR. The percentage difference in gene expression levels when compared between the morning and evening was then determined as referred to as morning-evening variation (MEV).</citation_analysis></p>
        </sec>
        <sec id="s2003">
          <title>Results</title>
          <p><citation_analysis attribute="neither">The MEV for </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> mRNA expression in OSA patients increased significantly by 23% (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.008) when compared to patients without OSA. The gene expression levels of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Timeless</italic></citation_analysis><citation_analysis attribute="neither"> (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.038) and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Cry2</italic></citation_analysis><citation_analysis attribute="neither"> (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.012) decreased with AHI. The MEV of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1, Rorα</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> mRNA levels were upregulated by 16% (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.006), 14% (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.027), and 25% (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.005), respectively, in participants with NH when compared to those without NH. Furthermore, the MEV for </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> mRNA levels was positively correlated with the MEV of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1, Cry1</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">CK1δ</italic></citation_analysis><citation_analysis attribute="neither"> mRNA levels (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = 0.638, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001; </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = 0.327, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.002; </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = 0.332, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.001, respectively) and negatively correlated with LSpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = −0.464, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> =0.009) and Mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = −0.500, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.003).</citation_analysis></p>
        </sec>
        <sec id="s2004">
          <title>Conclusion</title>
          <p><citation_analysis attribute="neither">Our data suggest that patients with OSA or NH tend to develop circadian rhythm disorders that may be induced by the hypoxia-mediated augmentation of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> gene expression in OSA.</citation_analysis></p>
        </sec>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords</title>
        <kwd>obstructive sleep apnea</kwd>
        <kwd>hypoxia-inducible factor</kwd>
        <kwd>circadian rhythm</kwd>
        <kwd>apnea hypopnea index</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
<institution-wrap><institution>the National Natural Science Foundation of China</institution></institution-wrap>
</funding-source>
        </award-group>
        <funding-statement>This study was supported by the National Natural Science Foundation of China (81570085) and CAMS Innovation Fund for Medical Sciences(CIFMS)(2021-I2M-C&amp;T-B-013).</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="3"/>
        <table-count count="4"/>
        <ref-count count="47"/>
        <page-count count="12"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s0001">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">Obstructive sleep apnea (OSA) syndrome is a partial or complete block of the airways that can cause hypopnea or apnea accompanied by a variety of clinical manifestations, including night snoring, daytime sleepiness, and a reduction in cognitive performance.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither"> OSA is estimated to affect 34% and 17% of middle-aged men and women in the general population;</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither"> the prevalence of this condition is increasing coincident with the epidemic of obesity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="negative"> Emerging data also suggest that the presence of OSA and nocturnal hypoxemia (NH) are constantly accompanied by an increased risk of hypertension,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither"> diabetes,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither"> coronary artery disease,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither"> and stroke.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="neither"> In OSA, the upper airway collapses repeatedly during sleep, thus causing cycles of apnea, arousal, and compensatory hyperventilation. Collectively, these events lead to alterations in day/night physiological and circadian gene expression and associated biological processes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8–10</xref></citation_analysis><citation_analysis attribute="neither"> In addition, hypoxic signals regulate the clock by slowing the circadian cycle and dampening the amplitude of oscillations in a dose-dependent manner.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="positive"> It is speculated that the disrupted expression of circadian genes induced by OSA through the hypoxia-inducible factor (HIF) pathway could result in an increased risk of a variety of metabolic diseases and cardiovascular diseases.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="neither"> Investigating the association between HIF and the expression of circadian genes could enhance our understanding of the pathophysiology of OSA and help reduce complications associated with this condition.</citation_analysis></p>
      <p><citation_analysis attribute="neither">The internal 24-h circadian clocks are achieved in humans and most mammals by the ocular photoreception of light from the environment and the relay of signals to the suprachiasmatic nucleus (SCN) in the hypothalamus.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="positive"> Previous studies suggested that the expression of clock genes in human monocytes isolated from peripheral whole blood could be used as indicators of changes in the central circadian rhythm.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither"> A genetic network of transcriptional and translational negative feedback loops generates rhythmic 24-h oscillations in the expression levels of core clock components. The major transcription factor, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1</italic></citation_analysis><citation_analysis attribute="neither">, interacts with </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Clock</italic></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">NPAS2</italic></citation_analysis><citation_analysis attribute="neither"> (the Clock homolog) to activate the circadian gene expression of their target genes including </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PER</italic></citation_analysis><citation_analysis attribute="neither"> (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PER1, PER2</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PER3), CRY</italic></citation_analysis><citation_analysis attribute="neither"> (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">CRY1</italic></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">CRY2), NR1D1</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">RORα</italic></citation_analysis><citation_analysis attribute="neither">.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="positive"> Although several studies have reported changes in the expression of canonical clock genes in patients with OSA,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18–21</xref></citation_analysis><citation_analysis attribute="neither"> the results derived from these studies were not consistent.</citation_analysis></p>
      <p><citation_analysis attribute="neither">HIF1 is a heterodimer consisting of an unstable HIF1α subunit and a constitutively expressed HIF1β subunit that is ubiquitously expressed in all tissues and functions as a primary regulator of oxygen homeostasis in humans.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="positive"> Gene expression array and chromatin immunoprecipitation assays have demonstrated that more than 1000 genes are directly trans-activated by HIF1 in response to hypoxia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="positive"> Several studies have reported an increase in HIF1α in patients with OSA when compared with control subjects.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="neither"> Furthermore, HIF1α has also been proven to exert functionality as the regulatory node that connects hypoxia signaling with the circadian clock.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="positive"> A body of evidence now suggests that HIF1 and circadian clock genes (eg, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1</italic></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Per2</italic></citation_analysis><citation_analysis attribute="neither">) undergo bidirectional interactions.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither"> According to these previous studies, we know little about the specific interactions between </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> and clock genes in patients with OSA; furthermore, existing information is not consistent.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">In this study, we investigated the disturbance in circadian clock gene expression in subjects experiencing different severities of OSA without any other complications. Secondly, we aimed to investigate the association between the expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1</italic></citation_analysis><citation_analysis attribute="neither">α and clock genes in patients with OSA to gain a further understanding of the effect of intermittent hypoxia induced by OSA on genes responsible for circadian rhythm.</citation_analysis></p>
    </sec>
    <sec id="s0002">
      <title>Materials and Methods</title>
      <sec id="s0002-s2001">
        <title>Participants</title>
        <p><citation_analysis attribute="positive">Polysomnography (PSG) was carried out in accordance with the American Academy of Sleep Medicine (AASM) manual 2.5 in order to score sleep and associated events.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="neither"> PSG results were then used to consecutively recruit 21 males with an apnea hypopnea index (AHI) ≥ 15 events/h and 22 male controls (mean AHI: 1.6 events/h). Patients were all recruited between August 2019 and December 2019 from the Sleep Disordered Breathing Laboratory of Peking Union Medical College Hospital (PUMCH). The present study was carried out as described previously.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="positive"> The exclusion criteria were as follows: (1) patients who had been treated for sleep apnea by continuous positive airway pressure (CPAP); (2) patients with self-reported chronic diseases including uncontrolled hypertension, chronic liver diseases, chronic kidney diseases, chronic lung diseases, perivascular diseases, heart diseases, diabetes, thromboembolism diseases, tumor, nerve system diseases and mental diseases; (3) patients with acute infectious over the previous two weeks; and (4) patients who performed shift work and slept for less than 6 h. Written and informed consent was provided by all participants. The study was approved by the PUMCH ethics committee (protocol number: JS-2013) and conducted in accordance with the Declaration of Helsinki.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2002">
        <title>Polysomnography and the Definition of Key Sleep Variables</title>
        <p><citation_analysis attribute="positive">Overnight PSG was performed using an Embla N7000 system (Natus Medical Incorporated, USA) from 10 PM to 6 AM in the sleep-disordered breathing laboratory of our hospital. The overall process and manual scoring were performed by skilled technicians who were supervised by experienced sleep physicians in accordance with the AASM manual 2.5.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="neither"> The AHI was defined as the total number of apnea and hypopnea events per hour of sleep. LSpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> was defined as the lowest pulse oxygen saturation during sleep. The oxygen desaturation index (ODI) was defined as the frequency of instances when the blood oxygen levels decreased (desaturation) by 3% or more. T90 was defined as the percentage of time when the oxygen saturation was &lt; 90% during the period of monitoring. An AHI ≥15 events/h was used as a cutoff to divide the patients into two groups: the control group featuring patients with an AHI &lt;15 events/h and an OSA group of patients with an AHI ≥15 events/h based on the International Classification of Sleep Disorders (3rd Edition).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="neither"> In addition, we classified patients with a T90 &gt; 0 into a nocturnal hypoxemia (NH) group and those with a T90 = 0 as a no NH group.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2003">
        <title>Clock Gene Expression and Biological Measurements</title>
        <p><citation_analysis attribute="positive">Samples of whole peripheral blood were collected on the evening (9–10 PM) before and early morning (6–7 AM) after PSG using PAXGene Blood RNA tubes (2.5 mL) in the sleep-disordered breathing laboratory and then stored at −80°C. Samples were processed within 6 months of acquisition. RNA was isolated with a PAXGene Blood RNA kit in accordance with the manufacturer’s instructions (QIAGEN, Germany). Total RNA was converted to cDNA using a Prime Script RT Master Mix kit (TAKARA, Japan). Relative gene expression was then quantified by quantitative real-time reverse transcription-polymerase chain reaction (RT-qPCR) performed on an Applied Biosystems StepOnePlus Real-time PCR system (Applied Biosystems, USA), using Fast SYBR Green Master Mix (Applied Biosystems, USA). Relative gene expression was analyzed by the 2</citation_analysis><citation_analysis attribute="positive"><sup>−ΔΔCt</sup></citation_analysis><citation_analysis attribute="neither"> method</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="neither"> and normalized relative to the expression levels of glyceraldehyde 3-phosphate dehydrogenase (GAPDH).</citation_analysis></p>
        <p><citation_analysis attribute="neither">All reactions were performed in duplicate, and mean expression levels for each transcript were used for analyses. The target genes were as follows: </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Timeless, Clock, Bmal1, Per1, Per2, Per3, Cry1, Cry2, Ck1δ, Rorα, NR1D1, NPAS2, HIF1α</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1β</italic></citation_analysis><citation_analysis attribute="neither">. Forward and reverse primers specific for each gene of interest are listed in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">.</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0001"><label>Table 1</label><caption><p><citation_analysis attribute="neither">Primer Sequence Details of the Analyzed Gene (F: Forward Primer, R: Reverse Primer)</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Sequence</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Human_Gapdh _F</td><td rowspan="1" colspan="1">TCGGAGTCAACGGATTTGGT</td></tr><tr><td rowspan="1" colspan="1">Human_Gapdh _R</td><td rowspan="1" colspan="1">TTCCCGTTCTCAGCCTTGAC</td></tr><tr><td rowspan="1" colspan="1">Human_Timeless _F</td><td rowspan="1" colspan="1">AGGAGCGGAGTGCAGATTTT</td></tr><tr><td rowspan="1" colspan="1">Human_Timeless _R</td><td rowspan="1" colspan="1">TCGAGAATGCCTGTTGCCTC</td></tr><tr><td rowspan="1" colspan="1">Human_Clock _F</td><td rowspan="1" colspan="1">AAGTTAGGGCTGAAAGACGACGA</td></tr><tr><td rowspan="1" colspan="1">Human_Clock _R</td><td rowspan="1" colspan="1">GAACTCCGAGAAGAGGCAGAAG</td></tr><tr><td rowspan="1" colspan="1">Human_Bmal1 _F</td><td rowspan="1" colspan="1">AGGATGGCTGTTCAGCACATGA</td></tr><tr><td rowspan="1" colspan="1">Human_Bmal1 _R</td><td rowspan="1" colspan="1">CAAAAATCCATCTGCTGCCCTG</td></tr><tr><td rowspan="1" colspan="1">Human_Per1_F</td><td rowspan="1" colspan="1">CTGAGGAGGCCGAGAGGAAAGAA</td></tr><tr><td rowspan="1" colspan="1">Human_Per1_R</td><td rowspan="1" colspan="1">AGGAGGAGGAGGCACATTTAC</td></tr><tr><td rowspan="1" colspan="1">Human_ Per 2_F</td><td rowspan="1" colspan="1">AAGCAGGTGAAAGCCAATGAAGA</td></tr><tr><td rowspan="1" colspan="1">Human_ Per 2 _R</td><td rowspan="1" colspan="1">CCACCGCAAACATATCGGCATT</td></tr><tr><td rowspan="1" colspan="1">Human_ Per 3_F</td><td rowspan="1" colspan="1">TGCAGGGCATCCTCCCTTTGA</td></tr><tr><td rowspan="1" colspan="1">Human_ Per 3_R</td><td rowspan="1" colspan="1">TCCGGCTCCAGGGATTCACAA</td></tr><tr><td rowspan="1" colspan="1">Human_ Cry1_F</td><td rowspan="1" colspan="1">CTGCGTCTACATCCTGGACC</td></tr><tr><td rowspan="1" colspan="1">Human_ Cry1_R</td><td rowspan="1" colspan="1">GAAGCAAAAATCGCCACCTGT</td></tr><tr><td rowspan="1" colspan="1">Human_ Cry2_F</td><td rowspan="1" colspan="1">TCCCTAGCATGTCAGCCCGTT</td></tr><tr><td rowspan="1" colspan="1">Human_ Cry2_R</td><td rowspan="1" colspan="1">AGGATTTGAGGCACTGTTCCGA</td></tr><tr><td rowspan="1" colspan="1">Human_ Ck1δ_F</td><td rowspan="1" colspan="1">CTCACAGAATAGCATTCCTTTCG</td></tr><tr><td rowspan="1" colspan="1">Human_ Ck1δ_R</td><td rowspan="1" colspan="1">TGCACGACAGACTGAAGACC</td></tr><tr><td rowspan="1" colspan="1">Human_ Rorα_F</td><td rowspan="1" colspan="1">TCGCAGCGATGAAAGCTCAAAT</td></tr><tr><td rowspan="1" colspan="1">Human_ Rorα_R</td><td rowspan="1" colspan="1">GTGGCATTGCTTTGCTGACT</td></tr><tr><td rowspan="1" colspan="1">Human_ NR1D1_F</td><td rowspan="1" colspan="1">ACAGCTGACACCACCCAGATC</td></tr><tr><td rowspan="1" colspan="1">Human_ NR1D1_R</td><td rowspan="1" colspan="1">CATGGGCATAGGTGAAGATTTCT</td></tr><tr><td rowspan="1" colspan="1">Human_ NPAS2_F</td><td rowspan="1" colspan="1">ATCCTGCAGGCCAATATCCG</td></tr><tr><td rowspan="1" colspan="1">Human_ NPAS2_R</td><td rowspan="1" colspan="1">CTGCTGCAGGAACATCTGGA</td></tr><tr><td rowspan="1" colspan="1">Human_ HIF1α_F</td><td rowspan="1" colspan="1">GCCGCTGGAGACACAATCAT</td></tr><tr><td rowspan="1" colspan="1">Human_ HIF1α_R</td><td rowspan="1" colspan="1">GAAGTGGCTTTGGCGTTTCA</td></tr><tr><td rowspan="1" colspan="1">Human_ HIF1β_F</td><td rowspan="1" colspan="1">GACTACTGCCAACCCCGAAA</td></tr><tr><td rowspan="1" colspan="1">Human_ HIF1β_R</td><td rowspan="1" colspan="1">CTCATCATCCGACCTGGCAA</td></tr></tbody></table></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
        <p><citation_analysis attribute="positive">The levels of key biochemical parameters were determined in fasting peripheral blood within 1 h using standard techniques. Plasma was obtained after centrifugation for 30 min at 3000 g at 4°C for 15 min, stored at −20°C for less than 1 week and then transferred to −80°C. Plasma levels of HIF1α were measured in batches within 6 months of acquisition using a Human/Mouse Total HIF1α ELISA kit (R&amp;D Systems, USA) in accordance with the manufacturer’s protocol.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2004">
        <title>Statistical Analysis</title>
        <p><citation_analysis attribute="positive">All calculations were performed using SPSS version 22.0 (IBM, USA) and GraphPad Prism 5.0 (GraphPad, USA). The normality of variables was assessed by the Kolmogorov–Smirnov normality test. We used t-tests or Chi-squared tests to compare between groups for normally distributed variables and categorical variables, respectively. The non-parametric Mann–Whitney </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">U</italic></citation_analysis><citation_analysis attribute="neither">-test was used when data were not normally distributed. An ANOVA or Kruskal–Wallis test was used for non-parametric multi-group comparisons. For each sample of whole blood, CT data were examined, and samples in which the expression level of GAPDH was ≥23, thus indicating unreliable; these samples were excluded from our analyses. Gene expression data were analyzed by comparing the mean fold change of transcript levels between groups. The percentage difference between morning and evening (</citation_analysis><citation_analysis attribute="positive"><inline-formula id="ilm0001"><alternatives><inline-graphic xlink:href="NSS-14-381-e0001.jpg"/><tex-math id="Tex001">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${{morning - evening} \over {evening}}$$
\end{document}</tex-math></alternatives></inline-formula></citation_analysis><citation_analysis attribute="neither">) was used to describe morning-evening variation (MEV). Pearson’s or Spearman’s methods were used to analyze the correlation between gene expression and PSG results. </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05 was considered statistically significant.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>Results</title>
      <sec id="s0003-s2001">
        <title>Characteristics of Participants</title>
        <p><citation_analysis attribute="positive">Demographic variables, clinical characteristics, PSG parameters, and laboratory data are shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="positive">. The mean age of the cohort was 39 years (range, 26–56 years); there was no significant difference between the control and OSA groups in terms of age. The mean body mass index (BMI) was 26.6 kg/m</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither"> and was significantly higher in OSA (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.001) or NH (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001) subjects than those in the control group. In addition, 49% of the study cohort were diagnosed as NH because T90 (percent of time spent with SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> below 90%) was &gt; 0. After adjustment for age and BMI, the serum HbA1c (hemoglobin A1C) levels in OSA patients were significantly higher than those of the control participants (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.03). Moreover, the levels of glucose, HbA1c, and ALT (Alanine aminotransferase) in patients with NH were significantly higher than the subjects in the no NH group after adjusting for age and BMI (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.022, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.033 and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.039, respectively). AHI, ODI, mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, LSpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> (%, lowest pulse oxygen saturation), and T90 (%) are greatly increased both in patients with OSA or NH.</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0002" orientation="landscape"><label>Table 2</label><caption><p><citation_analysis attribute="neither">General Characteristics of the Study Participants</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Control (AHI&lt;15 Events/h, n=22)</th><th rowspan="1" colspan="1">OSA (AHI≥15 Events/h, n=21)</th><th rowspan="1" colspan="1">P value</th><th rowspan="1" colspan="1">no NH (T90&lt;0, n=22)</th><th rowspan="1" colspan="1">NH (T90&gt;0, n=21)</th><th rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">39.0±7.8</td><td rowspan="1" colspan="1">38.9±8.3</td><td rowspan="1" colspan="1">0.969</td><td rowspan="1" colspan="1">37.5±6.9</td><td rowspan="1" colspan="1">40.4±8.8</td><td rowspan="1" colspan="1">0.238</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m2)</td><td rowspan="1" colspan="1">25.1±3.1</td><td rowspan="1" colspan="1">28.1±2.4</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1">25.0±3.1</td><td rowspan="1" colspan="1">28.2±2.3</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Current smokers(n)</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.457</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">1.000</td></tr><tr><td rowspan="1" colspan="1">Hypertension (n)</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">0.203</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">0.055</td></tr><tr><td rowspan="1" colspan="1">AHI (events/h)</td><td rowspan="1" colspan="1">1.6 (0.6, 6.9)</td><td rowspan="1" colspan="1">42.4 (21.1, 63.1)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.6 (0.6, 8.6)</td><td rowspan="1" colspan="1">40.4 (18.2, 63.2)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">ODI (events/h)</td><td rowspan="1" colspan="1">1.4(0.3,4.9)</td><td rowspan="1" colspan="1">38.6(19.1,60.1)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.4(0.3,4.9)</td><td rowspan="1" colspan="1">38.6(17.0,60.1)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Mean SpO<sub>2</sub>(%)</td><td rowspan="1" colspan="1">97.3 (95.6, 98.1)</td><td rowspan="1" colspan="1">95.8 (94.0, 97.4)</td><td rowspan="1" colspan="1">0.029</td><td rowspan="1" colspan="1">97.7 (95.8, 98.4)</td><td rowspan="1" colspan="1">95.1 (94.0, 96.7)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">LSpO<sub>2</sub>(%)</td><td rowspan="1" colspan="1">91.6±4.0</td><td rowspan="1" colspan="1">81.7±6.7</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">92.4±2.6</td><td rowspan="1" colspan="1">80.8±5.8</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">T90(%)</td><td rowspan="1" colspan="1">0(0, 0)</td><td rowspan="1" colspan="1">0.6(0.2,1.6)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">0(0, 0)</td><td rowspan="1" colspan="1">0.6(0.3, 1.6)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">ALT(U/L)</td><td rowspan="1" colspan="1">25(19, 35.5)</td><td rowspan="1" colspan="1">46(27.5, 56)</td><td rowspan="1" colspan="1">0.017</td><td rowspan="1" colspan="1">25(19, 33.2)</td><td rowspan="1" colspan="1">44(27.5, 62.5)</td><td rowspan="1" colspan="1">0.011</td></tr><tr><td rowspan="1" colspan="1">Cr (umol/L)</td><td rowspan="1" colspan="1">80.1±8.2</td><td rowspan="1" colspan="1">75.4±11.5</td><td rowspan="1" colspan="1">0.128</td><td rowspan="1" colspan="1">80.3±7.8</td><td rowspan="1" colspan="1">75.2±11.7</td><td rowspan="1" colspan="1">0.099</td></tr><tr><td rowspan="1" colspan="1">Glucose (mmol/L)</td><td rowspan="1" colspan="1">4.9±0.6</td><td rowspan="1" colspan="1">5.2±0.6</td><td rowspan="1" colspan="1">0.082</td><td rowspan="1" colspan="1">4.8±0.6</td><td rowspan="1" colspan="1">5.3±0.6</td><td rowspan="1" colspan="1">0.008</td></tr><tr><td rowspan="1" colspan="1">HBA1C(%)</td><td rowspan="1" colspan="1">5.2(5.0, 5.5)</td><td rowspan="1" colspan="1">5.5(5.3, 5.6)</td><td rowspan="1" colspan="1">0.025</td><td rowspan="1" colspan="1">5.2(5.0, 5.5)</td><td rowspan="1" colspan="1">5.5(5.4, 5.6)</td><td rowspan="1" colspan="1">0.006</td></tr><tr><td rowspan="1" colspan="1">TG (mmol/L)</td><td rowspan="1" colspan="1">1.1(0.8, 1.8)</td><td rowspan="1" colspan="1">2.4(1.5, 4.2)</td><td rowspan="1" colspan="1">0.004</td><td rowspan="1" colspan="1">1.1(0.8, 1.8)</td><td rowspan="1" colspan="1">2.4(1.5, 4.2)</td><td rowspan="1" colspan="1">0.004</td></tr><tr><td rowspan="1" colspan="1">TC (mmol/L)</td><td rowspan="1" colspan="1">4.7±0.7</td><td rowspan="1" colspan="1">4.8±0.8</td><td rowspan="1" colspan="1">0.722</td><td rowspan="1" colspan="1">4.7±0.7</td><td rowspan="1" colspan="1">4.8±0.8</td><td rowspan="1" colspan="1">0.965</td></tr><tr><td rowspan="1" colspan="1">LDL (mmol/L)</td><td rowspan="1" colspan="1">3.2±0.7</td><td rowspan="1" colspan="1">2.9±0.8</td><td rowspan="1" colspan="1">0.357</td><td rowspan="1" colspan="1">3.2±0.7</td><td rowspan="1" colspan="1">2.9±0.8</td><td rowspan="1" colspan="1">0.200</td></tr><tr><td rowspan="1" colspan="1">HDL (mmol/L)</td><td rowspan="1" colspan="1">1.2±0.3</td><td rowspan="1" colspan="1">1.0±0.2</td><td rowspan="1" colspan="1">0.026</td><td rowspan="1" colspan="1">1.2±0.3</td><td rowspan="1" colspan="1">1.0±0.2</td><td rowspan="1" colspan="1">0.005</td></tr><tr><td rowspan="1" colspan="1">UA (umol/L)</td><td rowspan="1" colspan="1">391.6±74.8</td><td rowspan="1" colspan="1">425.4±93.5</td><td rowspan="1" colspan="1">0.197</td><td rowspan="1" colspan="1">410.1±95.8</td><td rowspan="1" colspan="1">406.0±74.8</td><td rowspan="1" colspan="1">0.874</td></tr><tr><td rowspan="1" colspan="1">hsCRP (mg/L)</td><td rowspan="1" colspan="1">0.8(0.6, 1.1)</td><td rowspan="1" colspan="1">2.0(0.8, 2.6)</td><td rowspan="1" colspan="1">0.002</td><td rowspan="1" colspan="1">0.9(0.6, 1.8)</td><td rowspan="1" colspan="1">1.2(0.8, 2.4)</td><td rowspan="1" colspan="1">0.194</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: Data are presented as mean values and SD, counts, or medians and interquartile ranges, as appropriate. Differences tested by </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">t</italic></citation_analysis><citation_analysis attribute="neither">-test for each OSA subset against Controls.</citation_analysis></p></fn><fn id="tfn0002"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: AHI, Apnea-hypopnea index; ALT, Alanine aminotransferase; BMI, Body mass index; Cr, Creatinine; HBA1C, hemoglobin A1C; HDL, high-density lipoprotein; hsCRP, high-sensitivity C-reactive protein; LDL, low-density lipoprotein; LSpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, Lowest pulse arterial oxygen saturation; T90 (%), percent of time spent with SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> below 90%; TC, Total cholesterol; TG, Triglyceride; UA, Uric acid.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
      <sec id="s0003-s2002">
        <title>The mRNA Expression Levels of Clock Genes and HIF1α According to OSA Status</title>
        <p><citation_analysis attribute="positive">No significant differences were detected between the OSA and control group with regards to the mRNA expression levels of clock genes and HIF1a; this was the case for both the evening and morning samples (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive"> &gt; 0.05). No significant differences were identified between the evening and morning samples of both groups (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &gt; 0.05) in terms of the mRNA levels of clock genes and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &gt; 0.05). The MEVs of each target gene (the percentage difference for each gene) is depicted in </citation_analysis><citation_analysis attribute="positive"><xref rid="f0001" ref-type="fig">Figure 1A</xref></citation_analysis><citation_analysis attribute="neither">. Of these, the MEV for </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> mRNA expression increased by 23% in subjects with OSA when compared to those without OSA (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive"> = 0.008) after one night of sleep. However, no significant changes were detected in the expression levels of other clock genes when compared to control subjects. Further analysis detected a significant trend towards the downregulation of MEV for the </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Timeless</italic></citation_analysis><citation_analysis attribute="neither"> gene (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = −0.223, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.038) and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Cry2</italic></citation_analysis><citation_analysis attribute="neither"> gene (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = −0.348, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.012) as AHI values increased (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0001" ref-type="fig">Figure 1B</xref></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><xref rid="f0001" ref-type="fig">C</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0001" fig-type="figure"><label>Figure 1</label><caption><p><citation_analysis attribute="neither">The percentage difference of morning-evening variation in clock gene expression for subjects with and without OSA. (</citation_analysis><citation_analysis attribute="positive"><bold>A</bold></citation_analysis><citation_analysis attribute="neither">) expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> increased by 23% in subjects with OSA when compared with those without OSA (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.008) (</citation_analysis><citation_analysis attribute="positive"><bold>B</bold></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><bold>C</bold></citation_analysis><citation_analysis attribute="neither">) Relative gene expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Timeless</italic></citation_analysis><citation_analysis attribute="neither"> (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = −0.223, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.038) and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Cry2</italic></citation_analysis><citation_analysis attribute="neither"> (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither">= −0.348, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.012) in subjects with OSA decreased with increasing AHI. Data represent means ± SEM. **</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.01.</citation_analysis></p></caption><graphic xlink:href="NSS-14-381-g0001" content-type="print-only" position="float"/></fig></citation_analysis></p>
      </sec>
      <sec id="s0003-s2003">
        <title>The mRNA Expression Levels of Clock Genes and HIF1α According to NH Status</title>
        <p><citation_analysis attribute="neither">In the NH group, the MEVs of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1, Rorα</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> were upregulated by 16% (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.006), 14% (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.027), and 25% (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.005), respectively, when compared with the no NH group (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0002" ref-type="fig">Figure 2A</xref></citation_analysis><citation_analysis attribute="neither">). The mRNA expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1</italic></citation_analysis><citation_analysis attribute="neither"> mRNA in the morning decreased significantly after sleep in the no NH group (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.039), but not in the NH group (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0002" ref-type="fig">Figure 2B</xref></citation_analysis><citation_analysis attribute="neither">). A similar trend was also observed for the expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Rorα</italic></citation_analysis><citation_analysis attribute="neither">, although without statistical significance (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0002" ref-type="fig">Figure 2C</xref></citation_analysis><citation_analysis attribute="neither">). The mRNA levels of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> increased after a single night of sleep in the NH group but this change was not statistically significant. Analyses also showed that the evening levels of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> mRNA were significantly higher in the no NH group than in the NH group (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.003) (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0002" ref-type="fig">Figure 2D</xref></citation_analysis><citation_analysis attribute="positive">). Consequently, the protein levels of HIF1α in both groups had increased the following morning; however, these changes were not statistically significant due to wide variation and the small sample size in the NH and no NH groups at both time points (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0002" ref-type="fig">Figure 2E</xref></citation_analysis><citation_analysis attribute="neither">). No statistical differences were found for the mRNA expression levels of other clock genes when comparing the NH and no NH group at both time points or when comparing evening and morning samples for both groups.</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0002" fig-type="figure"><label>Figure 2</label><caption><p><citation_analysis attribute="neither">The percentage difference of morning-evening variation in clock gene expression for subjects with and without NH. (</citation_analysis><citation_analysis attribute="positive"><bold>A-D</bold></citation_analysis><citation_analysis attribute="neither">) The percentage difference of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1, Rorα</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> were up-regulated by 16% (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.006), 14% (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.027), and 25% (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.005), respectively, in subjects with nocturnal hypoxemia. (</citation_analysis><citation_analysis attribute="positive"><bold>E</bold></citation_analysis><citation_analysis attribute="positive">) The protein concentration of HIF1α was increased in patients with NH after one-night of hypoxia but did not reach a significant statistical difference. Data represent means ± SEM. * </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05, ** </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.01.</citation_analysis></p></caption><graphic xlink:href="NSS-14-381-g0002" content-type="print-only" position="float"/></fig></citation_analysis></p>
      </sec>
      <sec id="s0003-s2004">
        <title>Correlations Between the MEVs of HIF1α and the MEVs of Clock Gene and PSG Parameters</title>
        <p><citation_analysis attribute="neither">Next, we attempted to identify correlations between the MEVs of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> and clock genes mRNA expression levels and found that the MEV of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> mRNA levels was positively correlated with the MEVs of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1, Cry1</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">CK1δ</italic></citation_analysis><citation_analysis attribute="neither"> mRNA levels (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = 0.638, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001; </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = 0.327, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.002; </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = 0.332, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.001, respectively, </citation_analysis><citation_analysis attribute="positive"><xref rid="f0003" ref-type="fig">Figure 3A–C</xref></citation_analysis><citation_analysis attribute="neither">); the MEV of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> did not correlate with the expression of any of the other clock genes. We also investigated the MEVs of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="positive"> mRNA levels and PSG parameters. As shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="f0003" ref-type="fig">Figure 3F</xref></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><xref rid="f0003" ref-type="fig">G</xref></citation_analysis><citation_analysis attribute="neither">, the MEV of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> mRNA expression was negatively correlated with LSpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> (%) and mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> (%) (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = −0.46, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.009; </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = −0.5, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive"> = 0.003; respectively). There was no significant correlation between AHI, ODI, and the MEV for </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> mRNA.</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0003" fig-type="figure"><label>Figure 3</label><caption><p><citation_analysis attribute="neither">Correlations between morning-evening variation of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF-1α</italic></citation_analysis><citation_analysis attribute="neither"> and circadian genes mRNA levels (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1, Cry1</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">CK1δ</italic></citation_analysis><citation_analysis attribute="neither">), PSG parameters (AHI, ODI LSpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, and Mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">). (</citation_analysis><citation_analysis attribute="positive"><bold>A</bold></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><bold>C</bold></citation_analysis><citation_analysis attribute="neither">) Correlation between morning-evening variation for </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1, Cry1</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">CK1δ</italic></citation_analysis><citation_analysis attribute="neither"> mRNA level (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = 0.638, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001; </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = 0.327, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.032; </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">R</italic></citation_analysis><citation_analysis attribute="neither"> = 0.332, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.030, respectively). (</citation_analysis><citation_analysis attribute="positive"><bold>D</bold></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><bold>G</bold></citation_analysis><citation_analysis attribute="neither">) Correlation between morning-evening variation for </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> mRNA level and PSG parameters (AHI, ODI, LSpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, and Mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">) (R = 0.234, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.131; R = 0.277, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.072; R = −0.464, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.009; R = −0.500, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.003, respectively).</citation_analysis></p></caption><graphic xlink:href="NSS-14-381-g0003" content-type="print-only" position="float"/></fig></citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0004">
      <title>Discussion</title>
      <p><citation_analysis attribute="neither">In this preliminary study, we showed that patients with OSA or NH had a significantly higher MEV for </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1</italic></citation_analysis><citation_analysis attribute="neither">α mRNA expression. We also found that the MEVs for </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1</italic></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Ror</italic></citation_analysis><citation_analysis attribute="positive">α mRNA expression were significantly increased in patients with NH. In addition, we identified positive correlations between the MEVs for </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1, Cry1, CK1</italic></citation_analysis><citation_analysis attribute="neither">δ, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1</italic></citation_analysis><citation_analysis attribute="negative">α. Intermittent hypoxia is known to be the main contributor to OSA-related pathologies and place patients at a higher risk of developing multiple comorbidities.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0033" ref-type="bibr">33</xref></citation_analysis><citation_analysis attribute="positive"> Our findings suggest that an important interrelationship may exist between OSA-induced hypoxia and clock gene disturbance.</citation_analysis></p>
      <p><citation_analysis attribute="neither">We also observed a remarkable increase in the amplitude of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1</italic></citation_analysis><citation_analysis attribute="positive">α mRNA expression levels in the mornings in patients from the OSA or NH groups after one night of sleep. A similar trend, albeit not significant, was observed for the levels of HIF1α protein in subjects from the NH group. This may be explained by changes in post-translational regulation rather than transcriptional control which leads to a mismatch between </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1</italic></citation_analysis><citation_analysis attribute="neither">α expression at the mRNA and protein levels in blood serum. In addition, the MEV for </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1</italic></citation_analysis><citation_analysis attribute="neither">α mRNA level was negatively correlated with LSpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> and mean SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> but not AHI. These results further implied that more HIF1α were upregulated in response to acute hypoxia in one night than the chronic intermittent hypoxia induced by OSA. In fact, previous studies on the relationship between HIF1α and OSA are inconsistent.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0034" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="positive"> Our current findings are similar to those reported by Kaczmarek et al, who showed that the mRNA expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1</italic></citation_analysis><citation_analysis attribute="neither">α in skin biopsies in severely hypoxemic OSA patients was significantly higher than those in control subjects or those who had mildly hypoxemic OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0034" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="neither"> However, other studies found that the serum levels of HIF1α protein were chronically increased in patients with OSA when compared with control patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="positive"> In another study, Gabryelska et al found that the serum levels of HIF1α protein were higher in patients with OSA in both the evening and the morning; moreover, there were no significant differences between the OSA and control group with regards to </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1</italic></citation_analysis><citation_analysis attribute="neither">α mRNA expression.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="positive"> In comparison, we believe our findings might be due to the fact that a single night, with a reduction in the oxygen saturation of hemoglobin, may have directly affected the mRNA expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1</italic></citation_analysis><citation_analysis attribute="positive">α in the peripheral blood cells. However, this changes were not sufficient to cause a significant upregulation in the protein levels of HIF1α in our cohort of patients, who were relatively young OSA patients with a small BMI, and without significant complications. Another interpretation is that, during hypoxia, the overexpressed HIF1α protein translocate from the cytoplasm to the nucleus to form a transcriptionally active HIF1 complex via dimerization with HIF-1β to induce gene expression. Thus, the increase in serum HIF-1α protein was not so evident.</citation_analysis></p>
      <p><citation_analysis attribute="positive">Our results showed no significant changes in the expression of circadian rhythm genes in OSA patients, irrespective of whether we considered evening or morning time points. These findings are somewhat different from those described in previous studies, in which the changes of circadian genes are inconsistent neither. A cross-sectional analysis of 49 veterans with chronic kidney disease found that the expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Per3</italic></citation_analysis><citation_analysis attribute="neither"> was reduced in sleep apnea, and that the expression levels of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">NPAS2, Per1</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">NR1D1</italic></citation_analysis><citation_analysis attribute="neither"> were reduced in subjects with NH.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> Similarly, another study described the disruption of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Per1</italic></citation_analysis><citation_analysis attribute="neither"> mRNA expression levels in subjects with OSA and that CPAP treatment reversed this condition in 16 subjects.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="positive"> However, Moreira et al reported statistically significant differences for the expression of clock genes in 13 patients with severe OSA when compared to 8 healthy subjects; this condition was not reversed by CPAP therapy.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0021" ref-type="bibr">21</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Furthermore, our results showed that the MEVs for </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Cry2</italic></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Timeless</italic></citation_analysis><citation_analysis attribute="neither"> mRNA levels decreased with the increasing severity of sleep apnea. Cry1 and Cry2 are necessary for the maintenance of circadian behavioral rhythms; both circadian rhythmicity and light-induced suppression of pineal melatonin concentration were disturbed in Cry1 and Cry2 double-deficient mice.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0035" ref-type="bibr">35</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="neither"> Meanwhile, the human Timeless protein interacts with both Cry2 and cell cycle checkpoint proteins and plays an important role in the DNA damage checkpoint response.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="positive"> We speculated that OSA may influence the DNA repair process, or potentially apoptosis. Moreover, we identified a positive correlation between the mRNA levels of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Cry1</italic></citation_analysis><citation_analysis attribute="positive">; this was similar to previous findings in which the evening levels of Cry1 proteins were positively related to the levels of HIF1α protein.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0038" ref-type="bibr">38</xref></citation_analysis><citation_analysis attribute="neither"> According to our current study, the two isoforms of Cry protein may play opposing roles in OSA and NH.</citation_analysis></p>
      <p><citation_analysis attribute="neither">After a single night in the presence of apnea and hypoxia, we found that the gene expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1, Rorα</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> were enhanced in participants with NH when compared to the control group. In addition, the MEV for </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1</italic></citation_analysis><citation_analysis attribute="neither"> was also positively correlated with the expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither">. Previous reports showed that Rorα can directly activate the transcription of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1</italic></citation_analysis><citation_analysis attribute="neither">, thereby maintaining a robust circadian rhythm in the peripheral tissues,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0039" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither"> and the murine SCN.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0040" ref-type="bibr">40</xref></citation_analysis><citation_analysis attribute="neither"> Simultaneously, transcription of the </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Rorα</italic></citation_analysis><citation_analysis attribute="neither"> gene appeared to be upregulated by hypoxia in a panel of cell lines derived from different human tissues.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0041" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither"> Moreover, it is known that </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1</italic></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Rorα</italic></citation_analysis><citation_analysis attribute="neither"> form a regulatory loop and increase the transcriptional activity of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> within the nucleus.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0042" ref-type="bibr">42</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither"> Consistent with this view, our data showed that the mRNA expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Rorα</italic></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> were both upregulated in the morning after one night of hypoxia. Therefore, our results provide a new insight for the function of Rorα in the amplification of hypoxia signaling. Further research is now needed to elucidate the potential role of Rorα in OSA. CK1δ is a serine/threonine-specific kinase that phosphorylates HIF1α at S247 to reduce its affinity for its hetero-dimerization partner HIF-1β.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0045" ref-type="bibr">45</xref></citation_analysis><citation_analysis attribute="neither"> Studies also showed that the silencing of CK1δ enhanced the activity of HIF1 under hypoxic conditions while the overexpression of CK1δ inhibited HIF1 activity under such conditions; these data suggest the importance of the CK1δ-dependent phosphorylation of HIF1α.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither"> In the present study, the enhancement of CK1δ expression under hypoxic conditions may contribute to the accumulation of HIF1α protein in patients with OSA.</citation_analysis></p>
      <p><citation_analysis attribute="neither">The current study had key advantages that need to be highlighted. For example, only a very limited number of human studies have been published relating to the potential association between </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="positive"> and clock gene expression in patients with OSA. Secondly, our methodology was clinically accessible and implemented efficiently. In our study, we only included males without any severe comorbidities; in this manner, we were able to reduce the potential effects of confounding factors because OSA is a heterogeneous disease with different clinical phenotypes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0047" ref-type="bibr">47</xref></citation_analysis><citation_analysis attribute="neither"> However, there are some limitations that need to be considered. First, we only analyzed the effect of hypoxia on </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> and clock genes after one night; we did not consider data over longer periods of time. Further research is now needed to investigate the mRNA and protein levels of HIF1α at more time points during the day and determine the precise correlations between HIF1α expression at the mRNA and protein levels. Secondly, the relatively small sample size limits the generalizability of our conclusions; future studies should be conducted in a larger OSA cohort to investigate the expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> and clock genes in a more comprehensive manner.</citation_analysis></p>
    </sec>
    <sec id="s0005">
      <title>Conclusions</title>
      <p><citation_analysis attribute="neither">In conclusion, the current study indicated that OSA was associated with some alterations in the expression of several clock genes, including </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Timeless, Cry1, Cry2, Bmal1, Rorα</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">CK1δ</italic></citation_analysis><citation_analysis attribute="neither">. Interestingly, these disruptions in clock gene expression may be mediated by HIF1α; the mRNA morning–evening variation for </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither"> was positively correlated with the expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1, Cry1</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">CK1δ</italic></citation_analysis><citation_analysis attribute="positive">. Our findings suggest that OSA and OSA-related nocturnal hypoxia may be associated with the altered expression of clock genes during the response to hypoxia. A better understanding of the direction and magnitude of the association between OSA and 24-h gene expression patterns of key clock genes may open the door for the development of novel therapeutic targets to treat OSA-related complications.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p><citation_analysis attribute="neither">The help from Hairong Zhang, Shuning Li in collecting data is greatly appreciated. Informed consent was obtained from all participants involved in the study. All authors have seen and approved the submitted version of this manuscript.</citation_analysis></p>
    </ack>
    <sec id="s0006">
      <title>Brief Summary</title>
      <p><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><list list-type="order"><list-item><p><citation_analysis attribute="positive">There is a significant lack of literature relating to circadian clock disruption in patients experiencing OSA. This study aimed to investigate the relationship between </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1α</italic></citation_analysis><citation_analysis attribute="neither">, a series of circadian clock genes, and polysomnography variables.</citation_analysis></p></list-item><list-item><p><citation_analysis attribute="positive">Data highlight the positive association between the mRNA expression of a series of clock genes and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">HIF1</italic></citation_analysis><citation_analysis attribute="neither">α: a trend towards the downregulation of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Timeless</italic></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Cry2</italic></citation_analysis><citation_analysis attribute="neither"> with increasing OSA severity, and an increase in the morning-evening variation of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Bmal1</italic></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Rorα</italic></citation_analysis><citation_analysis attribute="neither"> mRNA expression in patients with NH. Findings enhance our understanding of the complex relationship between intermittent hypoxia, circadian rhythms, and OSA.</citation_analysis></p></list-item></list></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
    </sec>
    <sec id="s0007">
      <title>Abbreviations</title>
      <p><citation_analysis attribute="positive">AASM, American Academy of Sleep Medicine; AHI, apnea-hypopnea index; ALT, alanine aminotransferase; BMI, body mass index; CK1, casein kinase 1; CPAP, continuous positive airway pressure; Cr, creatinine; Cry, cryptochrome; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HBA1C, hemoglobin A1C; HDL, high-density lipoprotein; HIF1α, hypoxia-inducible factor 1α; hsCRP, high-sensitivity C-reactive protein; LDL, low-density lipoprotein; LSpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, Lowest pulse arterial oxygen saturation; MEV, morning-evening variation; NH, nocturnal hypoxemia; OSA, obstructive sleep apnea; Per, period; PSG, polysomnography; PUMCH, Peking Union Medical School of Hospital; RT-qPCR, quantitative real-time polymerase chain reaction; SCN, suprachiasmatic nucleus; SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, oxygen saturation; T90 (%), Sleep time spent with oxygen saturation &lt; 90%; TBA, total bile acid; TC, total cholesterol; TG, triglyceride; UA, uric acid.</citation_analysis></p>
    </sec>
    <sec sec-type="COI-statement" id="s0008">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">The authors declare no conflicts of interest in this work.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gottlieb</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Punjabi</surname>
<given-names>NM</given-names></string-name>. <article-title>Diagnosis and management of obstructive sleep apnea: a review</article-title>. <source><italic toggle="yes">JAMA J Am Med Assoc</italic></source>. <year>2020</year>;<volume>323</volume>(<issue>14</issue>):<fpage>1389</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2020.3514</pub-id></mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Peppard</surname>
<given-names>PE</given-names></string-name>, <string-name><surname>Young</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Barnet</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Palta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hagen</surname>
<given-names>EW</given-names></string-name>, <string-name><surname>Hla</surname>
<given-names>KM</given-names></string-name>. <article-title>Increased prevalence of sleep-disordered breathing in adults</article-title>. <source><italic toggle="yes">Am J Epidemiol</italic></source>. <year>2013</year>;<volume>177</volume>(<issue>9</issue>):<fpage>1006</fpage>–<lpage>1014</lpage>. doi:<pub-id pub-id-type="doi">10.1093/aje/kws342</pub-id><pub-id pub-id-type="pmid">23589584</pub-id></mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Garvey</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Pengo</surname>
<given-names>MF</given-names></string-name>, <string-name><surname>Drakatos</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Kent</surname>
<given-names>BD</given-names></string-name>. <article-title>Epidemiological aspects of obstructive sleep apnea</article-title>. <source><italic toggle="yes">J Thorac Dis</italic></source>. <year>2015</year>;<volume>7</volume>(<issue>5</issue>):<fpage>920</fpage>–<lpage>929</lpage>. doi:<pub-id pub-id-type="doi">10.3978/j.issn.2072-1439.2015.04.52</pub-id><pub-id pub-id-type="pmid">26101650</pub-id></mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bangash</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Wajid</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Poolacherla</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Mim</surname>
<given-names>FK</given-names></string-name>, <string-name><surname>Rutkofsky</surname>
<given-names>IH</given-names></string-name>. <article-title>Obstructive Sleep Apnea and Hypertension: a Review of the Relationship and Pathogenic Association</article-title>. <source><italic toggle="yes">Cureus</italic></source>. <year>2020</year>;<volume>12</volume>(<issue>5</issue>):<fpage>e8241</fpage>–<lpage>e8241</lpage>. doi:<pub-id pub-id-type="doi">10.7759/cureus.8241</pub-id><pub-id pub-id-type="pmid">32582500</pub-id></mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Doumit</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Prasad</surname>
<given-names>B</given-names></string-name>. <article-title>Sleep Apnea in Type 2 Diabetes</article-title>. <source><italic toggle="yes">Diabetes Spectrum</italic></source>. <year>2016</year>;<volume>29</volume>(<issue>1</issue>):<fpage>14</fpage>. doi:<pub-id pub-id-type="doi">10.2337/diaspect.29.1.14</pub-id><pub-id pub-id-type="pmid">26912960</pub-id></mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kent</surname>
<given-names>BD</given-names></string-name>, <string-name><surname>Garvey</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Ryan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Nolan</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Dodd</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>McNicholas</surname>
<given-names>WT</given-names></string-name>. <article-title>Severity of obstructive sleep apnoea predicts coronary artery plaque burden: a coronary computed tomographic angiography study</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2013</year>;<volume>42</volume>(<issue>5</issue>):<fpage>1263</fpage>. doi:<pub-id pub-id-type="doi">10.1183/09031936.00094812</pub-id><pub-id pub-id-type="pmid">23471346</pub-id></mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yaggi</surname>
<given-names>HK</given-names></string-name>, <string-name><surname>Concato</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kernan</surname>
<given-names>WN</given-names></string-name>, <string-name><surname>Lichtman</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Brass</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Mohsenin</surname>
<given-names>V</given-names></string-name>. <article-title>Obstructive Sleep Apnea as a Risk Factor for Stroke and Death</article-title>. <source><italic toggle="yes">N Eng J Med</italic></source>. <year>2005</year>;<volume>353</volume>(<issue>19</issue>):<fpage>2034</fpage>–<lpage>2041</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa043104</pub-id></mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Butler</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Thosar</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Smales</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Effects of obstructive sleep apnea on endogenous circadian rhythms assessed during relaxed wakefulness; an exploratory analysis</article-title>. <source><italic toggle="yes">Chronobiol Int</italic></source>. <year>2020</year>;<volume>37</volume>(<issue>6</issue>):<fpage>856</fpage>–<lpage>866</lpage>. doi:<pub-id pub-id-type="doi">10.1080/07420528.2020.1740723</pub-id><pub-id pub-id-type="pmid">32192382</pub-id></mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Manella</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Aviram</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bolshette</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Muvkadi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Asher</surname>
<given-names>G</given-names></string-name>. <article-title>Hypoxia induces a time- And tissue-specific response that elicits intertissue circadian clock misalignment</article-title>. <source><italic toggle="yes">Proc National Acad Sci</italic></source>. <year>2019</year>;<volume>117</volume>(<issue>1</issue>):<fpage>201914112</fpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1914112117</pub-id></mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>O’Connell</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Martinez</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Liang</surname>
<given-names>YG</given-names></string-name>, <string-name><surname>Cistulli</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Cook</surname>
<given-names>KM</given-names></string-name>. <article-title>Out of Breath, Out of Time: interactions between HIF and Circadian Rhythms</article-title>. <source><italic toggle="yes">AJP Cell Physiology</italic></source>. <year>2020</year>;<volume>319</volume>(<issue>3</issue>):<fpage>9857</fpage>. doi:<pub-id pub-id-type="doi">10.1152/ajpcell.00305.2020</pub-id></mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Reciprocal Regulation between the Circadian Clock and Hypoxia Signaling at the Genome Level in Mammals</article-title>. <source><italic toggle="yes">Cell Metab</italic></source>. <year>2017</year>;<volume>25</volume>(<issue>1</issue>):<fpage>73</fpage>–<lpage>85</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2016.09.009</pub-id><pub-id pub-id-type="pmid">27773697</pub-id></mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Turkiewicz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Karuga</surname>
<given-names>FF</given-names></string-name>, <string-name><surname>Sochal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Strzelecki</surname>
<given-names>D</given-names></string-name>, <string-name><surname>BiaBasiewicz</surname>
<given-names>P</given-names></string-name>. <article-title>Disruption of Circadian Rhythm Genes in Obstructive Sleep Apnea Patient“ Possible Mechanisms Involved and Clinical Implication</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2022</year>;<fpage>23</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms23020709</pub-id></mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kramer</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Merrow</surname>
<given-names>M</given-names></string-name>. <article-title>Circadian Clocks</article-title>. <source><italic toggle="yes">Handb Exp Pharmacol</italic></source>. <year>2013</year>;<volume>148</volume>(<issue>5</issue>):<fpage>S29</fpage>.</mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Burioka</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Takata</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Endo</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Treatment with β 2 ‐Adrenoceptor Agonist in Vivo Induces Human Clock Gene, Per1, mRNA Expression in Peripheral Blood</article-title>. <source><italic toggle="yes">Chronobiol Int</italic></source>. <year>2007</year>;<volume>24</volume>:<fpage>183</fpage>–<lpage>189</lpage>. doi:<pub-id pub-id-type="doi">10.1080/07420520601140043</pub-id><pub-id pub-id-type="pmid">17364588</pub-id></mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Boivin</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>James</surname>
<given-names>FO</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cho-Park</surname>
<given-names>PF</given-names></string-name>, <string-name><surname>Xiong</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>ZS</given-names></string-name>. <article-title>Circadian clock genes oscillate in human peripheral blood mononuclear cells</article-title>. <source><italic toggle="yes">Blood</italic></source>. <year>2003</year>;<volume>102</volume>(<issue>12</issue>):<fpage>4143</fpage>–<lpage>4145</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2003-03-0779</pub-id><pub-id pub-id-type="pmid">12893774</pub-id></mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Reppert</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Weaver</surname>
<given-names>DR</given-names></string-name>. <article-title>Coordination of circadian timing in mammals</article-title>. <source><italic toggle="yes">Nature</italic></source>. <year>2002</year>;<volume>418</volume>(<issue>6901</issue>):<fpage>935</fpage>–<lpage>941</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature00965</pub-id><pub-id pub-id-type="pmid">12198538</pub-id></mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Schibler</surname>
<given-names>U</given-names></string-name>. <article-title>The daily timing of gene expression and physiology in mammals</article-title>. <source><italic toggle="yes">Dialogues Clin Neurosci</italic></source>. <year>2007</year>;<volume>9</volume>(<issue>3</issue>):<fpage>257</fpage>–<lpage>272</lpage>. doi:<pub-id pub-id-type="doi">10.31887/DCNS.2007.9.3/uschibler</pub-id><pub-id pub-id-type="pmid">17969863</pub-id></mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yang</surname>
<given-names>M-Y</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>P-W</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>H-C</given-names></string-name>, et al. <article-title>Alternations of Circadian Clock Genes Expression and Oscillation in Obstructive Sleep Apnea</article-title>. <source><italic toggle="yes">J Clin Med</italic></source>. <year>2019</year>;<volume>8</volume>(<issue>10</issue>):<fpage>987</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm8101634</pub-id></mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Canales</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>Holzworth</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bozorgmehri</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Clock gene expression is altered in veterans with sleep apnea</article-title>. <source><italic toggle="yes">Physiol Genomics</italic></source>. <year>2019</year>;<volume>51</volume>(<issue>3</issue>):<fpage>77</fpage>–<lpage>82</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physiolgenomics.00091</pub-id><pub-id pub-id-type="pmid">30657733</pub-id></mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Burioka</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Koyanagi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Endo</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Clock gene dysfunction in patients with obstructive sleep apnoea syndrome</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2008</year>;<volume>32</volume>(<issue>1</issue>):<fpage>105</fpage>. doi:<pub-id pub-id-type="doi">10.1183/09031936.00138207</pub-id><pub-id pub-id-type="pmid">18321934</pub-id></mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Moreira</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Rodrigues</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Barros</surname>
<given-names>AB</given-names></string-name>, et al. <article-title>Changes in Expression of the CLOCK Gene in Obstructive Sleep Apnea Syndrome Patients Are Not Reverted by Continuous Positive Airway Pressure Treatment</article-title>. <source><italic toggle="yes">Front Med</italic></source>. <year>2017</year>;<volume>4</volume>:<fpage>187</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmed.2017.00187</pub-id></mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>GL</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>BH</given-names></string-name>, <string-name><surname>Rue</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Semenza</surname>
<given-names>GL</given-names></string-name>. <article-title>Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension</article-title>. <source><italic toggle="yes">Proc National Acad Sci</italic></source>. <year>1995</year>;<volume>92</volume>(<issue>12</issue>):<fpage>5510</fpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.92.12.5510</pub-id></mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Manalo</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Rowan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lavoie</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1</article-title>. <source><italic toggle="yes">Blood</italic></source>. <year>2005</year>;<volume>105</volume>:<fpage>659</fpage>–<lpage>669</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2004-07-2958</pub-id><pub-id pub-id-type="pmid">15374877</pub-id></mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Schödel</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Oikonomopoulos</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ragoussis</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Pugh</surname>
<given-names>CW</given-names></string-name>, <string-name><surname>Ratcliffe</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>Mole</surname>
<given-names>DR</given-names></string-name>. <article-title>High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq</article-title>. <source><italic toggle="yes">Blood</italic></source>. <year>2011</year>;<volume>117</volume>(<issue>23</issue>):<fpage>e207</fpage>–<lpage>17</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2010-10-314427</pub-id><pub-id pub-id-type="pmid">21447827</pub-id></mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Szmyd</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Panek</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Szemraj</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Biaasiewicz</surname>
<given-names>P</given-names></string-name>. <article-title>Serum Hypoxia-Inducible Factor-1α protein level as a diagnostic marker of obstructive sleep apnea</article-title>. <source><italic toggle="yes">Polskie Archiwum Medycyny Wewn</italic></source>. <year>2019</year>;<volume>130</volume>(<issue>2</issue>):<fpage>287</fpage>. doi:<pub-id pub-id-type="doi">10.20452/pamw.15104</pub-id></mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Szmyd</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Szemraj</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Stawski</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Sochal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Białasiewicz</surname>
<given-names>P</given-names></string-name>. <article-title>Patients with obstructive sleep apnea present with chronic upregulation of serum HIF-1α protein</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2020</year>;<volume>16</volume>(<issue>10</issue>):<fpage>1761</fpage>–<lpage>1768</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.8682</pub-id><pub-id pub-id-type="pmid">32663129</pub-id></mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kobayashi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Morinibu</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Koyasu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Goto</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Hiraoka</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Harada</surname>
<given-names>H</given-names></string-name>. <article-title>A circadian clock gene, PER2, activates HIF-1 as an effector molecule for recruitment of HIF-1α to promoter regions of its downstream genes</article-title>. <source><italic toggle="yes">FEBS J</italic></source>. <year>2017</year>;<volume>284</volume>(<issue>22</issue>):<fpage>3804</fpage>–<lpage>3816</lpage>. doi:<pub-id pub-id-type="doi">10.1111/febs.14280</pub-id><pub-id pub-id-type="pmid">28963769</pub-id></mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Peek</surname>
<given-names>CB</given-names></string-name>, <string-name><surname>Levine</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>Cedernaes</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Circadian Clock Interaction with HIF1α Mediates Oxygenic Metabolism and Anaerobic Glycolysis in Skeletal Muscle</article-title>. <source><italic toggle="yes">Cell Metab</italic></source>. <year>2017</year>;<volume>25</volume>(<issue>1</issue>):<fpage>86</fpage>–<lpage>92</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2016.09.010</pub-id><pub-id pub-id-type="pmid">27773696</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Stawski</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Sochal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Szmyd</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Bialasiewicz</surname>
<given-names>P</given-names></string-name>. <article-title>Influence of one‐night CPAP therapy on the changes of HIF‐1α protein in OSA patients: a pilot study</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2020</year>. doi:<pub-id pub-id-type="doi">10.1111/jsr.12995</pub-id></mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Berry</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Albertario</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Harding</surname>
<given-names>SM</given-names></string-name>, et al. <article-title>The AASM Manual for the Scoring of Sleep and Associated Events: rules, Terminology and Technical Specifications</article-title>. <source><italic toggle="yes">Original Res</italic></source>. <year>2018</year>:<volume>2018</volume>;<fpage>76</fpage>.</mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Luo</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>Z</given-names></string-name>, et al. <article-title>Endothelial Function and Arterial Stiffness Should Be Measured to Comprehensively Assess Obstructive Sleep Apnea in Clinical Practice. Original Research</article-title>. <source><italic toggle="yes">Front Cardiovascular Med</italic></source>. <year>2021</year>;<volume>2021</volume>:<fpage>8</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fcvm.2021.716916</pub-id></mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Livak</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Schmittgen</surname>
<given-names>TD</given-names></string-name>. <article-title>Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2<sup>−ΔΔCT</sup> Method</article-title>. <source><italic toggle="yes">Methods</italic></source>. <year>2001</year>;<volume>25</volume>(<issue>4</issue>):<fpage>402</fpage>–<lpage>408</lpage>. doi:<pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="book"><collab>American Academy of Sleep Medicine</collab>. <source><italic toggle="yes">International Classification of Sleep Disorders</italic></source>. <edition>3rd</edition> ed. <publisher-loc>Darien. IL</publisher-loc>: <publisher-name>American Academy of Sleep Medicine</publisher-name>; <year>2014</year>.</mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kaczmarek</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Bakker</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Clarke</surname>
<given-names>DN</given-names></string-name>, et al. <article-title>Molecular biomarkers of vascular dysfunction in obstructive sleep apnea</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2013</year>;<volume>8</volume>(<issue>7</issue>):<fpage>e70559</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0070559</pub-id><pub-id pub-id-type="pmid">23923005</pub-id></mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Horst</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Muijtjens</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kobayashi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Takano</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Yasui</surname>
<given-names>A</given-names></string-name>. <article-title>Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms</article-title>. <source><italic toggle="yes">Nature</italic></source>. <year>1999</year>;<volume>398</volume>(<issue>6728</issue>):<fpage>627</fpage>–<lpage>630</lpage>. doi:<pub-id pub-id-type="doi">10.1038/19323</pub-id><pub-id pub-id-type="pmid">10217146</pub-id></mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yamanaka</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Todo</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Honma</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Honma</surname>
<given-names>S</given-names></string-name>. <article-title>Loss of circadian rhythm and light-induced suppression of pineal melatonin levels in Cry1 and Cry2 double-deficient mice</article-title>. <source><italic toggle="yes">Genes to Cells</italic></source>. <year>2010</year>;<volume>15</volume>(<issue>10</issue>):<fpage>1063</fpage>–<lpage>1071</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2443.2010.01443.x</pub-id><pub-id pub-id-type="pmid">20825493</pub-id></mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Unsal-Kaçmaz</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Mullen</surname>
<given-names>TE</given-names></string-name>, <string-name><surname>Kaufmann</surname>
<given-names>WK</given-names></string-name>, <string-name><surname>Sancar</surname>
<given-names>A</given-names></string-name>. <article-title>Coupling of human circadian and cell cycles by the timeless protein</article-title>. <source><italic toggle="yes">Mol Cell Biol</italic></source>. <year>2005</year>;<volume>25</volume>(<issue>8</issue>):<fpage>3109</fpage>–<lpage>3116</lpage>. doi:<pub-id pub-id-type="doi">10.1128/mcb.25.8.3109-3116.2005</pub-id><pub-id pub-id-type="pmid">15798197</pub-id></mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sochal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Turkiewicz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Biaasiewicz</surname>
<given-names>P</given-names></string-name>. <article-title>Relationship between HIF-1 and Circadian Clock Proteins in Obstructive Sleep Apnea Patients—Preliminary Study</article-title>. <source><italic toggle="yes">J Clin Med</italic></source>. <year>2020</year>;<volume>9</volume>(<issue>5</issue>):<fpage>1599</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm9051599</pub-id></mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Akashi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Takumi</surname>
<given-names>T</given-names></string-name>. <article-title>The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1</article-title>. <source><italic toggle="yes">Nat Struct Mol Biol</italic></source>. <year>2005</year>;<volume>12</volume>(<issue>5</issue>):<fpage>441</fpage>–<lpage>448</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nsmb925</pub-id><pub-id pub-id-type="pmid">15821743</pub-id></mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sato</surname>
<given-names>TK</given-names></string-name>, <string-name><surname>Panda</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Miraglia</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Reyes</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Hogenesch</surname>
<given-names>JB</given-names></string-name>. <article-title>A functional genomics strategy reveals Rora as a component of the mammalian circadian clock</article-title>. <source><italic toggle="yes">Neuron</italic></source>. <year>2004</year>;<volume>43</volume>(<issue>4</issue>):<fpage>527</fpage>–<lpage>537</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuron.2004.07.018</pub-id><pub-id pub-id-type="pmid">15312651</pub-id></mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hongyu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Longjian</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Jun</surname>
<given-names>D</given-names></string-name>. <article-title>Retinoic acid receptor-related orphan receptor ROR regulates differentiation and survival of keratinocytes during hypoxia</article-title>. <source><italic toggle="yes">J Cell Physiol</italic></source>. <year>2018</year>;<volume>233</volume>(<issue>1</issue>):<fpage>641</fpage>–<lpage>650</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05739.x</pub-id><pub-id pub-id-type="pmid">28332183</pub-id></mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Suyama</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Silagi</surname>
<given-names>ES</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Circadian factors BMAL1 and RORα control HIF-1α transcriptional activity in nucleus pulposus cells: implications in maintenance of intervertebral disc health</article-title>. <source><italic toggle="yes">Oncotarget</italic></source>. <year>2014</year>;<volume>7</volume>(<issue>17</issue>):<fpage>786</fpage>. doi:<pub-id pub-id-type="doi">10.18632/oncotarget.8521</pub-id></mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chauvet</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Bois-Joyeux</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Berra</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Pouyssegur</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Danan</surname>
<given-names>JL</given-names></string-name>. <article-title>The gene encoding human retinoic acid-receptor-related orphan receptor alpha is a target for hypoxia-inducible factor 1</article-title>. <source><italic toggle="yes">Biochem J</italic></source>. <year>2004</year>;<volume>384</volume>(<issue>Pt 1</issue>):<fpage>84</fpage>. doi:<pub-id pub-id-type="doi">10.1042/BJ20040709</pub-id></mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kalousi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mylonis</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Politou</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Chachami</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Simos</surname>
<given-names>G</given-names></string-name>. <article-title>Casein kinase 1 regulates human hypoxia-inducible factor HIF-1</article-title>. <source><italic toggle="yes">J Cell Sci</italic></source>. <year>2010</year>;<volume>123</volume>(<issue>Pt 17</issue>):<fpage>2976</fpage>–<lpage>2986</lpage>. doi:<pub-id pub-id-type="doi">10.1242/jcs.068122</pub-id><pub-id pub-id-type="pmid">20699359</pub-id></mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kourti</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ikonomou</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Giakoumakis</surname>
<given-names>-N-N</given-names></string-name>, et al. <article-title>CK1δ restrains lipin-1 induction, lipid droplet formation and cell proliferation under hypoxia by reducing HIF-1α/ARNT complex formation</article-title>. <source><italic toggle="yes">Cell Signal</italic></source>. <year>2015</year>;<volume>27</volume>(<issue>6</issue>):<fpage>1129</fpage>–<lpage>1140</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cellsig.2015.02.017</pub-id><pub-id pub-id-type="pmid">25744540</pub-id></mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Koyasu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kobayashi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Goto</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Hiraoka</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Harada</surname>
<given-names>H</given-names></string-name>. <article-title>Regulatory mechanisms of hypoxia-inducible factor 1 activity: two decades of knowledge</article-title>. <source><italic toggle="yes">Cancer Sci</italic></source>. <year>2018</year>;<volume>109</volume>(<issue>3</issue>):<fpage>560</fpage>–<lpage>571</lpage>. doi:<pub-id pub-id-type="doi">10.1111/cas.13483</pub-id><pub-id pub-id-type="pmid">29285833</pub-id></mixed-citation>
      </ref>
      <ref id="cit0047">
        <label>47.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Keenan</surname>
<given-names>BT</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>B</given-names></string-name>, et al. <article-title>Recognizable clinical subtypes of obstructive sleep apnea across international sleep centers: a cluster analysis</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2018</year>;<volume>41</volume>(<issue>3</issue>):<fpage>zsx214</fpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/zsx214</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
